260 related articles for article (PubMed ID: 15925494)
1. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.
Khan FH; Sen T; Maiti AK; Jana S; Chatterjee U; Chakrabarti S
Biochim Biophys Acta; 2005 Jun; 1741(1-2):65-74. PubMed ID: 15925494
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease.
Jana S; Sinha M; Chanda D; Roy T; Banerjee K; Munshi S; Patro BS; Chakrabarti S
Biochim Biophys Acta; 2011 Jun; 1812(6):663-73. PubMed ID: 21377526
[TBL] [Abstract][Full Text] [Related]
3. Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease.
Jana S; Maiti AK; Bagh MB; Banerjee K; Das A; Roy A; Chakrabarti S
Brain Res; 2007 Mar; 1139():195-200. PubMed ID: 17291463
[TBL] [Abstract][Full Text] [Related]
4. Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain.
Khan FH; Sen T; Chakrabarti S
Free Radic Res; 2003 Jun; 37(6):597-601. PubMed ID: 12868486
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.
Gluck MR; Zeevalk GD
J Neurochem; 2004 Nov; 91(4):788-95. PubMed ID: 15525332
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides.
Gluck M; Ehrhart J; Jayatilleke E; Zeevalk GD
J Neurochem; 2002 Jul; 82(1):66-74. PubMed ID: 12091466
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease.
Nunes C; Almeida L; Laranjinha J
Neurochem Int; 2005 Aug; 47(3):173-82. PubMed ID: 15893407
[TBL] [Abstract][Full Text] [Related]
8. Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease.
Bagh MB; Maiti AK; Jana S; Banerjee K; Roy A; Chakrabarti S
Free Radic Res; 2008 Jun; 42(6):574-81. PubMed ID: 18569015
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities.
Gautam AH; Zeevalk GD
Biochim Biophys Acta; 2011 Jul; 1807(7):819-28. PubMed ID: 21463600
[TBL] [Abstract][Full Text] [Related]
10. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
Shen XM; Li H; Dryhurst G
J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
[TBL] [Abstract][Full Text] [Related]
11. Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain.
Khan FH; Saha M; Chakrabarti S
Brain Res; 2001 Mar; 895(1-2):245-9. PubMed ID: 11259784
[TBL] [Abstract][Full Text] [Related]
12. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.
Berman SB; Hastings TG
J Neurochem; 1999 Sep; 73(3):1127-37. PubMed ID: 10461904
[TBL] [Abstract][Full Text] [Related]
13. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
Hermida-Ameijeiras A; Méndez-Alvarez E; Sánchez-Iglesias S; Sanmartín-Suárez C; Soto-Otero R
Neurochem Int; 2004 Jul; 45(1):103-16. PubMed ID: 15082228
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease.
Bisaglia M; Soriano ME; Arduini I; Mammi S; Bubacco L
Biochim Biophys Acta; 2010 Sep; 1802(9):699-706. PubMed ID: 20600874
[TBL] [Abstract][Full Text] [Related]
15. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
Li H; Shen XM; Dryhurst G
J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
[TBL] [Abstract][Full Text] [Related]
16. Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity.
Shen XM; Dryhurst G
Chem Res Toxicol; 1998 Jul; 11(7):824-37. PubMed ID: 9671546
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
Hsu M; Srinivas B; Kumar J; Subramanian R; Andersen J
J Neurochem; 2005 Mar; 92(5):1091-103. PubMed ID: 15715660
[TBL] [Abstract][Full Text] [Related]
18. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.
Asanuma M; Miyazaki I; Ogawa N
Neurotox Res; 2003; 5(3):165-76. PubMed ID: 12835121
[TBL] [Abstract][Full Text] [Related]
19. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
[TBL] [Abstract][Full Text] [Related]
20. Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia.
Brenner-Lavie H; Klein E; Zuk R; Gazawi H; Ljubuncic P; Ben-Shachar D
Biochim Biophys Acta; 2008 Feb; 1777(2):173-85. PubMed ID: 17996721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
